+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of female lower urinary tract symptoms: overview and update



Evaluation of female lower urinary tract symptoms: overview and update



Current Opinion in Obstetrics and Gynecology 13(5): 521-527



Female lower urinary tract symptoms are nonspecific, and a thorough clinical evaluation is required to establish the correct diagnosis. Such evaluation should consist of a structured micturition history or questionnaire, physical examination with full bladder, micturition diary, pad test and urodynamic evaluation. The urodynamic evaluation should consist at least of cystometry, detrusor pressure/uroflow study, simple ('free') uroflowmetry, assessment of the relative contribution of urethral hypermobility and intrinsic sphincter deficiency, and estimation of postvoid residual urine by ultrasound or catheterization. Recent studies regarding the role of pad tests, micturition diaries and urodynamic studies in the evaluation of female voiding dysfunction are presented. Factors that are associated with the use of transurethral catheter during pressure-flow studies and current controversies regarding the diagnosis of female bladder outlet obstruction are reviewed and discussed. Although the urodynamic study is considered to be the best diagnostic tool in assessment of lower urinary tract function, some practitioners believe that urodynamic evaluation is not routinely warranted and prefer to employ a symptom-based empirical management strategy. Lower urinary tract symptoms are nonspecific, however, and should be used mainly to identify what bothers the patient. Urodynamic studies define the underlying pathophysiology. We believe that treatment of the underlying pathophysiology facilitates better treatment of symptoms.

(PDF emailed within 0-6 h: $19.90)

Accession: 046009798

Download citation: RISBibTeXText

PMID: 11547034

DOI: 10.1097/00001703-200110000-00012


Related references

Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study. International Journal of Urology 18(11): 778-784, 2012

Update on lower urinary tract symptoms. Thescientificworldjournal 9: 499-500, 2009

Relationship of estimated glomerular filtration rate with lower urinary tract symptoms/benign prostatic hyperplasia measures in middle-aged men with moderate to severe lower urinary tract symptoms. Urology 82(6): 1381-1385, 2014

Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. Journal of Urology 196(3): 824-830, 2018

Lower urinary tract symptoms and urinary flow rates in female patients with hyperthyroidism. Urology 77(1): 50-54, 2011

Controversies in the management of lower urinary tract symptoms: an overview. British Journal of Urology 81 Suppl 1: 1-5; Discussion 64-6, 1998

Re: the impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. Journal of Urology 185(2): 601-602, 2016

The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. Journal of Sexual Medicine 5(6): 1418-1423, 2008

Tamsulosin: an update of its role in the management of lower urinary tract symptoms. Drugs 62(1): 135-167, 2002

Update on the medical treatment of lower urinary tract symptoms (LUTS) in men. Semergen 42(1): 31-37, 2017

Community divergence and convergence along experimental gradients of stress and disturbance. Ecology 99(4): 775-781, 2018

Prevalence of lower urinary tract symptoms in Austrian males: update 2009. Urologia Internationalis 87(4): 385-391, 2012

Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview. Current Opinion in Urology 24(4): 352-357, 2015

Re: Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview. Journal of Urology 193(1): 219-220, 2015

An Evidence Based Update on the Investigation and Management of Male Lower Urinary Tract Symptoms. Urologiia 2015(2): 94-102, 2015